LegisTrack
Back to all bills
HR 5630119th CongressIn Committee

To amend the Public Health Service Act to require additional information in State plans for Substance Use Prevention, Treatment, and Recovery Services block grants.

Introduced: Sep 30, 2025
HealthcareSocial Services
Standard Summary
Comprehensive overview in 1-2 paragraphs

The bill would modify the Public Health Service Act to require states that receive Substance Use Prevention, Treatment, and Recovery Services block grants to include additional information in their state plans. Specifically, it adds a new item (xi) to the information states must describe, detailing: (I) the types of drugs used for medication-assisted treatment (MAT) within the state’s care system; (II) the MAT programs or protocols used to prevent diversion and misuse and to enforce standards; (III) data on misuse of MAT drugs (including cases where MAT meds are mixed with other prescription drugs); and (IV) data on drug screening protocols within the state’s care system, including any special protocols for screening MAT patients. The aim is to increase transparency, monitoring, and safety around MAT and related practices.

Key Points

  • 1Adds a new required component (xi) to the state plan for SUD prevention, treatment, and recovery services block grants.
  • 2Requires states to describe the types of medications used for medication-assisted treatment (MAT).
  • 3Requires disclosure of MAT programs or protocols aimed at diversion prevention, misuse prevention, and enforcement.
  • 4Requires state data on misuse of MAT drugs, including mixing MAT meds with other prescription drugs.
  • 5Requires state data on drug screening protocols within the care system, including protocols specific to MAT patients.

Impact Areas

Primary group/area affected: State health departments and agencies administering Substance Use Prevention, Treatment, and Recovery Services block grants; individuals receiving MAT services.Secondary group/area affected: MAT providers and treatment programs; data collection and reporting systems; law enforcement and policy bodies involved in diversion/misuse prevention.Additional impacts: Increased reporting and data collection burden on states; potential privacy and data-security considerations; greater federal oversight and accountability for MAT practices and screening protocols; could influence program design and clinical practices related to MAT and drug screening.
Generated by gpt-5-nano on Oct 8, 2025